1. A composition comprising:
a) Adhatoda vasica extract; and
b) Cissus quadrangularis extract,
U@ wherein the Adhatoda vasica extract to the Cissus quadrangularis
extract weight ratio is in a range of 1:1.2 to 1:5.
2. The composition as claimed in claim 1, wherein the Adhatoda vasica extract
to the Cissus quadrangularis extract weight ratio is in a range of 1:1.5 to 1:4.
3. The composition as claimed in claim 1, wherein the Adhatoda vasica extract
QP@ has a weight percentage in a range of 0.0008 % to 0.0016% with respect to
the composition.
4. The composition as claimed in claim 1, wherein the Cissus quadrangularis
extract has a weight percentage in a range of 0.0024% to 0.0032% with
respect to the composition.
QU@ 5. The composition as claimed in claim 1, wherein the Adhatoda vasica extract
comprises total alkaloids in a range of 2-4% with respect to the Adhatoda vasica extract, and vasicine in a range of 1-2% with respect to the Adhatoda vasica extract.
6. The composition as claimed in claim 1, wherein the Cissus quadrangularis
RP@ extract comprises ketosterones in a range of 10-12% with respect to the
Cissus quadrangularis extract, and natural calcium in a range of 1-2% with respect to the Cissus quadrangularis extract.
7. The composition as claimed in claim 1, wherein the composition further
comprises at least one excipient selected from a group consisting of carriers,
RU@ diluents, flavouring agents, colouring agents, emulsifiers, buffering agents,
sweeteners, and combinations thereof.
8. A process for preparing a composition as claimed in claim 1, said process
comprises:
a) obtaining the Adhatoda vasica extract;
SP@ b) obtaining the Cissus quadrangularis extract; and

c) contacting the Adhatoda vasica extract, and the Cissus
quadrangularis extract, to obtain the composition.
9. A process for preparing the composition as claimed in claim 7, said process
comprises:
U@ a) obtaining the Adhatoda vasica extract;
b) obtaining the Cissus quadrangularis extract;
c) obtaining the at least one excipient; and
d) contacting the Adhatoda vasica extract, the Cissus quadrangularis extract, and the at least one excipient, to obtain the composition.
QP@ 10. The composition as claimed in any one of the claims 1-6, wherein the
composition inhibits the production of tartarate resistant acid phosphatase (TRAP) and inhibits activity of cathepsin K. 11. The composition as claimed in any one of the claims 1-6, wherein the composition inhibits osteoclast mediated bone resorption.